The Lord Prior of Brampton
Conservative
Member of the House of Lords
M
Lord Prior of Brampton's full title is The Lord Prior of Brampton. His name is David Gifford Leathes Prior, and he is a current member of the House of Lords.
Allowance claims · 2026
Data not yet released for 2026 — the Lords Finance Office publishes monthly CSVs ~6-8 weeks after month-end.
Lords votes · 2026
162 divisions
30 Content(18.5%)
4 Not-Content(2.5%)
128 didn't vote(79.0%)
2026-02-04
Not-Content
62–295
Not-Content
2026-01-12
Content
201–169
Content
Source: lordsvotes-api.parliament.uk. "Result" shows the headline
Content vs Not-Content tally (including tellers). The Lords doesn't
publish a "didn't vote" attendance roll like the Commons, so the
figure above conflates absence with abstention.
Recent Hansard contributions · latest 25
2025-10-23
Steel Industry (Special Measures) Act 2025
My Lords, I rise with some trepidation, looking across at the new Minister, as we know that she not only has the face of an angel but has balls of steel. I could apply both of those descriptions to the noble Baroness, Lady Hunter, as well. I thought the
2021-12-07
Health and Care Bill
My Lords, I should first refer to my declaration of interest—in particular, that I am currently chairman of NHS England. Looking down at the noble Lord, Lord Stevens, and also seeing the noble Lord, Lord Adebowale, and the noble Baroness, Lady Harding, I
2019-07-02
Academic Health Science Centres
My Lords, I should first declare an interest as chairman of NHS England and a non-executive director of Genomics England. I support the noble Lord, Lord Butler, especially and all the arguments other noble Lords have made.
I will begin by taking noble
My Lords, I first declare my interest as chairman of UCLH. The Select Committee has produced an outstanding report and I pay tribute to the noble Lord, Lord Patel—I was going to say my noble friend. He is a mentor to not only the noble Lord, Lord Kakkar;
2018-01-08
Industrial Strategy
I am delighted to hear that.
In my view, the White Paper is more of an hors d’oeuvre than a main course: it acknowledges specifically that it is a work in progress and not the final result of our labours. We have not yet won the argument that an indus
2018-01-08
Industrial Strategy
My Lords, I am probably not the most objective commentator on this White Paper, having spent most of the past year working on it. However, I echo the words of the noble Lord, Lord Mandelson, who said he hoped that Greg Clark was at No. 10 today to be pra
2017-11-27
Industrial Strategy
My Lords, the reports after the Budget by the IFS, the Resolution Foundation and the OBR posited or forecast stagnant productivity for the next 10 years, following the stagnation of the last 10 years, which is a truly frightening prospect. Only one other
2017-10-25
Electricity Supplier Obligations (Amendment and Excluded Electricity) (Amendment) Regulations 2017
I thank the noble Baroness and the noble Lord for supporting these regulations. The noble Baroness referred to the balance in recognising that some industries are not able to compete on a level playing field if they are heavily penalised by their electri
2017-10-25
Electricity Supplier Obligations (Amendment and Excluded Electricity) (Amendment) Regulations 2017
My Lords, these regulations amend the Electricity Supplier Obligations (Amendment & Excluded Electricity) Regulations 2015. They make provision for indirectly exempting eligible energy-intensive industries from part of the cost of funding the contrac
2017-10-25
Electricity Supplier Obligations (Amendment and Excluded Electricity) (Amendment) Regulations 2017
That the draft Regulations laid before the House on 28 March be approved.
Relevant documents: 32nd Report, Session 2016–17, from the Secondary Legislation Scrutiny Committee, 27th Report, Session 2016–17, from the Joint Committee on Statutory Instr
The noble Lord is absolutely right: because it is an intermittent source, it is not eligible for the capacity market. I will have to write to him about whether or not the capacity market itself has brought forward alternative capacity beyond that which I
My Lords, I think that I can thank both the noble Baroness and the noble Lord for supporting the regulations. They are pretty technical and complicated, but they correct perhaps inevitable imperfections in the original legislation passed in 2013.
The
My Lords, the draft instrument seeks to amend two secondary legislation packages for the capacity market. The powers to make this implementing secondary legislation are found in the Energy Act 2013, which, following scrutiny in the House and the other pl
That the draft Regulations laid before the House on 23 March be approved.
Relevant documents: 27th Report, Session 2016–17, from the Joint Committee on Statutory Instruments
2017-10-25
European Union (Approvals) Bill
I will write to the noble Earl.
The noble Lord, Lord Mendelsohn, asked what our view would be if, between now and our leaving the EU, perhaps during the transition period, the EU decided it wanted to expand to cover, for example, Serbia, Albania and
2017-10-25
European Union (Approvals) Bill
I cannot answer that question today; I will write to the noble Earl. Is the question about the impact on Kosovo of Albania and Serbia joining the EU at some future point?
2017-10-25
European Union (Approvals) Bill
I thank the noble Baroness, Lady Ludford, and the noble Lord, Lord Mendelsohn, for their broad support for the Bill. I suspect that the noble Baroness knows more about the history of those treaties than I do. I do not know why we require primary legislat
2017-10-25
European Union (Approvals) Bill
The purpose of this Bill is to approve four draft decisions of the Council of the European Union. All four draft decisions rely on Article 352 of the Treaty on the Functioning of the EU. This allows the EU to take action to attain the objectives set out
2017-10-25
European Union (Approvals) Bill
That the Bill be now read a second time.
2017-10-23
Science and Innovation Strategy
I have two quick comments on that. First, place is very important. We cannot address this fundamental productivity problem that has been mentioned in the south-east—if this is a golden triangle strategy, we have failed, so place is very important. Second
2017-10-23
Science and Innovation Strategy
My Lords, I find myself in the slightly odd situation of being able to agree 110% with what the noble Lord, Lord Mendelsohn, has just said; I do not think there is anything between us at all. I thank the noble Lord, Lord Patel, for tabling the debate tod
2017-10-23
Life Sciences Industrial Strategy
My Lords, that is a good question that applies across the piece: companies find the NHS very difficult to sell into. The Government and NHS England are acutely conscious of that and we are, through our test bed, digital catalyst and EAMS programmes and o
2017-10-23
Life Sciences Industrial Strategy
NHS data is potentially a hugely valuable resource, with the huge proviso that we must always respect patient confidentiality and privacy. On that basis, the data that we have in the NHS from primary and secondary care, given that it is the biggest unive
2017-10-23
Life Sciences Industrial Strategy
My Lords, it is true that the life sciences industrial strategy was largely based on humans rather than plants or animals. That does not mean to say that we will not be having a strategy for other sectors of the economy as well, including plants and anim
2017-10-23
Life Sciences Industrial Strategy
My Lords, there is a strong case for increasing the amount of resources that go into R&D in the UK. It is true that about 1.7% of GDP goes into research at the moment, whereas the OECD average is 2.4% and many countries are aiming at 3%—Germany is lo
Source: hansard.parliament.uk via hansard-api. Snippets shown
verbatim from the search API; click any debate title for the full record.
Register of Interests · 26 entries on file
Declarations under the Lords Code of Conduct. Free text — no monetary values, no hours worked. A declaration that an interest exists, not a claim about its size.
Category 1: Remunerated employment etc.
-
Chairman, Bit Bio Limited
registered 2026-01-12
-
Venture partner, Population Health Partners (drug discovery)
registered 2025-11-26
-
Member, Innovation Advisory Council, British Land
registered 2025-10-06
-
Member, Novo Nordisk Sustainability Advisory Council
registered 2024-08-27 · amended 2025-04-05
-
Chairman, Science Capital Imperial (invests in early stage and growth stage companies)
registered 2024-08-08 · amended 2025-04-05
-
Global Senior Adviser giving corporate and geopolitical advice to Lazard (financial and strategic advisory services)
registered 2024-08-08 · amended 2025-04-05
-
Chairman, Shift Biosciences Ltd (drug discovery)
registered 2024-08-08 · amended 2025-04-05
-
Chairman, Tangram Therapeutics plc (formerly E-Therapeutics plc) (drug discovery)
registered 2024-08-08 · amended 2025-11-26
-
Director, Lazard & Co Limited (service company)
registered 2024-08-08 · amended 2025-04-05
-
Director, Lazard & Co Holdings Limited (financial and strategic advisory services)
registered 2024-08-08 · amended 2025-04-05
-
Director, Lazard & Co Services Limited (financial and strategic advisory services)
registered 2024-08-08 · amended 2025-04-05
Category 2: Shareholdings etc. (b)
-
Function Health (US blood-based diagnostics and MRI)
registered 2025-11-26
-
R1 (US revenue cycle management)
registered 2025-11-26
-
Population Health Partners (biotechnology financing)
registered 2025-11-24
-
Tern Group (overseas medical recruitment platform)
registered 2024-08-08 · amended 2025-04-05
-
Origin Sciences (colorectal diagnostics)
registered 2024-08-08 · amended 2025-04-05
-
Lazard Inc (investment bank)
registered 2024-08-08 · amended 2025-04-05
-
CoMind (medical technology, brain monitoring diagnostics)
registered 2024-08-08 · amended 2025-04-05
-
Shift BioScience (drug discovery)
registered 2024-08-08 · amended 2025-04-05
-
Asclepius EBT - System C (electronic health records)
registered 2024-08-08 · amended 2025-04-05
-
Automata (laboratory automation)
registered 2024-08-08 · amended 2025-04-05
-
Pharma CCX (pharmaceutical administration)
registered 2024-08-08 · amended 2025-04-05
-
Apollo Therapeutics (drug discovery)
registered 2024-08-08 · amended 2025-04-05
-
Tympa Health Limited (hearing care)
registered 2024-08-08 · amended 2025-04-05
-
Tops Holding Limited (auction house)
registered 2024-08-08 · amended 2025-04-05
Category 3: Land and property
-
Farm in Suffolk
registered 2025-11-26
Source: UK Parliament Members API (Lords register). Refreshed weekly.
Read the full
Lords Code of Conduct
for what each category covers and the disclosure thresholds.
Party history
2025-07-03 → present
Conservative
current
2018-10-04 → 2025-07-02
Non-affiliated
1997-05-01 → 2018-10-03
Conservative
Government posts
2016-12-21 → 2017-10-27
Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy)
2015-05-14 → 2016-12-21
Parliamentary Under-Secretary (Department of Health) (NHS Productivity)
Opposition posts
None recorded.
Committee memberships
1997-07-09 → 1998-06-15
Trade & Industry
Contact
Parliamentary office
contactholmember@parliament.uk
020 7219 5353 · House of Lords, London, SW1A 0PW
020 7219 5353 · House of Lords, London, SW1A 0PW
APPGs (2026) · 0 active officership(s)
No APPG officerships found for this peer. (Officer matching is by name —
if the parliamentary register lists them under a slightly different
form, the join may miss; check
/appgs directly.)
Written parliamentary questions · 2026
No written questions tabled in 2026.
Bills sponsored & supported · 2026
0 bills
0 as lead sponsor
0 as supporter
No bills sponsored or supported in 2026.
Source: UK Parliament Bills API. "Lead" sponsor is the
primary mover (sortOrder = 1); "Supporter" rows are
members of either House who
backed the bill at introduction. Year is the bill's first-reading
date.
Historic bills (all-time)
0 bills
0 as lead sponsor
0 as supporter
No bills sponsored or supported on record.
Same source as the year-scoped panel above, but unconstrained by
year. The "Sponsored" tag = lead sponsor; "Supported" = backed at
introduction. Sorted newest first.